Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-21
2011-06-21
Andres, Janet (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S314000, C514S406000, C548S375100
Reexamination Certificate
active
07964732
ABSTRACT:
This invention provides a compound of the formulaThese compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.
REFERENCES:
patent: 5580983 (1996-12-01), Kraus
patent: 6774136 (2004-08-01), Gerlach et al.
patent: 6979686 (2005-12-01), Naraian et al.
patent: 7084176 (2006-08-01), Morie et al.
patent: 7425641 (2008-09-01), Ries et al.
patent: 2003/0232818 (2003-12-01), Anderson et al.
patent: 2004/0102449 (2004-05-01), Wu et al.
patent: 2005/0009812 (2005-01-01), Seko et al.
patent: 2005/0020644 (2005-01-01), Bisaha et al.
patent: 2005/0165032 (2005-07-01), Norman et al.
patent: 2005/0165046 (2005-07-01), Hulme et al.
patent: 2005/0165049 (2005-07-01), Hulme et al.
patent: 2006/0183909 (2006-08-01), Schmitt et al.
patent: 2007/0105943 (2007-05-01), Nakamoto et al.
patent: 4423353 (1996-01-01), None
patent: 0492178 (1992-07-01), None
patent: 0719760 (1999-09-01), None
patent: 2827599 (2003-01-01), None
patent: 2389580 (2003-12-01), None
patent: WO 9403432 (1994-02-01), None
patent: WO 9509159 (1995-04-01), None
patent: WO 9631475 (1996-10-01), None
patent: WO 9924442 (1999-05-01), None
patent: WO 9926927 (1999-06-01), None
patent: WO 0042026 (2000-07-01), None
patent: WO 0042213 (2000-07-01), None
patent: WO 0064888 (2000-11-01), None
patent: WO 0071512 (2000-11-01), None
patent: WO 0073283 (2000-12-01), None
patent: WO 0076970 (2000-12-01), None
patent: WO 0076971 (2000-12-01), None
patent: WO 0110823 (2001-02-01), None
patent: WO 0147866 (2001-07-01), None
patent: WO 0200651 (2002-01-01), None
patent: WO 0216318 (2002-02-01), None
patent: WO 0234718 (2002-05-01), None
patent: WO 02080928 (2002-10-01), None
patent: WO 02085908 (2002-10-01), None
patent: WO 02100819 (2002-12-01), None
patent: WO 03014064 (2003-02-01), None
patent: WO 03029210 (2003-04-01), None
patent: WO 03030937 (2003-04-01), None
patent: WO 03035621 (2003-05-01), None
patent: WO 03045920 (2003-06-01), None
patent: WO 03068749 (2003-08-01), None
patent: WO 03080578 (2003-10-01), None
patent: WO 03080596 (2003-10-01), None
patent: WO 03086377 (2003-10-01), None
patent: WO 03104178 (2003-12-01), None
patent: WO 2004019933 (2004-03-01), None
patent: WO 2004047743 (2004-06-01), None
patent: WO 2004052370 (2004-06-01), None
patent: WO 2004058164 (2004-07-01), None
patent: WO 2004058176 (2004-07-01), None
patent: WO 2004069792 (2004-08-01), None
patent: WO 2004078114 (2004-09-01), None
patent: WO 2004080463 (2004-09-01), None
patent: WO 2004104018 (2004-12-01), None
patent: WO 2004108133 (2004-12-01), None
patent: WO 2004113331 (2004-12-01), None
patent: WO 2005003084 (2005-01-01), None
patent: WO 2005009962 (2005-02-01), None
patent: WO 2005021509 (2005-03-01), None
patent: WO 2005021553 (2005-03-01), None
patent: WO 2005033079 (2005-04-01), None
patent: WO 2005035526 (2005-04-01), None
patent: WO 2005087742 (2005-09-01), None
patent: WO 2005105760 (2005-11-01), None
patent: WO 2006016548 (2006-02-01), None
Vippagunta et al., Crystalline Solids, 48 Adv. Drug Delivery Rev. 3-26 (2001).
Simon Frantz, The Trouble with Making Combination Drugs, 5 Nature Rev. 881-82 (2006).
Siu, et al., Organic & Biomolecular Chemistry (2005), 3(17). pp. 3140-3160 (XP002478714).
Kariya, et al., Neuroscience Letters, vol. 392, pp. 2132-215 (2006).
Maeda, et al., Biol. Pharm. Bull., vol. 28(5), pp. 649-853 (2005).
Ding, et al., J. Med. Chem. vol. 48, p. 3171-3181 (2005).
Maeda, et al., Biorganic & Medicinal Chemistry, vol. 12, pp. 4351-4360 (2004).
Halder, et al., Science of Synthesis, vol. 16(9), pp. 251-313 (2004).
Uesato, et al., Bioorganic & Medicinal Chemistry Letters. vol. 12, pp. 1347-1349 (2002).
Buolamwini, et al., J. Med. Chem. vol. 45, pp. 841-852 (2002).
Marsilje, et al., Bioorganic & Medicinal Chemistry Letters, vol. 20, pp. 477-481 (2000).
Stanczak, et al., Pharmazie, vol. 53(3), pp. 156-161 (1998).
Burke, et al., J. Med. Chem., vol. 38, pp. 4171-4178 (1995).
Burke, et al., Bioorganic & Medicinal Chemistry Letters, vol. 2(12), pp. 1772-1774 (1992).
Lanza, et al., J. Med. Chem., vol. 35, pp. 252-258 (1992).
El-Kerdawy, et al., J. Pharmaceutical Sciences, vol. 73(11), pp. 1652-1653 (1984).
Nair, et al., J. Org. Chem., vol. 38(12). pp. 2185-2189 (1973).
Ando Koji
Calabrese Andrew Anthony
Duncton Matthew Alexander James
Futatsugi Kentaro
Hirano Misato
Andres Janet
Kispert Jennifer
Olson A. Dean
Pfizer Inc.
Rozof Timothy R
LandOfFree
Substituted bicyclocarboxyamide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted bicyclocarboxyamide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted bicyclocarboxyamide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701080